Patrícia Carreira - Concepedia

Author

Patrícia Carreira

Hospital Universitario 12 De Octubre ORCID

Also Known As

Alessandra Bruns, Andr Santos, Anna-Maria Hoffmann-Vold, Beatriz Joven, C Montecucco, Carlomaurizio Montecucco, Carlos Marras, Carlotta Cacciatore, Carreira, Patricia, Carreira, Patricia E

348

Publications

18.2K

Citations

H-Index

111

Concepts

All Affiliations

Hospital Universitario 12 De Octubre Research Institute Hospital 12 de Octubre Radboud University Nijmegen University College London Instituto de Parasitología y Biomedicina "López - Neyra"

About

Patrícia Carreira is an author at Hospital Universitario 12 De Octubre specializing in medicine, autoimmune disease, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	37	2.6K
2	Public Health	10	10	363
3	Allergy	5	5	146
4	Health Sciences	2	2	51
5	Engineering	1	1	63

Patrícia Carreira

124

Publications

15.4K

Citations

H-Index

Page 1

	Year	Citations
2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative F.H.J. van den Hoogen, Dinesh Khanna, Jaap Fransen, Arthritis & Rheumatism	2013	3.3K
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative F.H.J. van den Hoogen, Dinesh Khanna, Jaap Fransen, Annals of the Rheumatic Diseases	2013	2.8K
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database A. J. Tyndall, Bettina Bannert, M.J. Vonk, Annals of the Rheumatic Diseases	2010	1.4K
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial Dinesh Khanna, Celia J. F. Lin, Daniel E. Furst, The Lancet Respiratory Medicine Autoimmune DiseaseSystemic SclerodermaImmunologySystemic SclerosisMultiple Sclerosis	2020	612
Overexpression of the Cytokine BAFF and Autoimmunity Risk Maristella Steri, Valeria Orrù, Maria Laura Idda, New England Journal of Medicine	2017	383
A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis Brad H. Rovin, Neil Solomons, William F. Pendergraft, Kidney International Dose-ranging VoclosporinGlomerulonephritisAutoimmune DiseaseSystemic Lupus Erythematosus TreatmentLupus	2018	290
The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements Anna‐Maria Hoffmann‐Vold, Toby M. Maher, E. Philpot, The Lancet Rheumatology Advanced Lung DiseaseSystemic SclerosisPulmonary FibrosisSclerodermaMedicine	2020	286
Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study Veronika K. Jaeger, Elina G. Wirz, Yannick Allanore, PLoS ONE	2016	264
The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index Gabriele Valentini, Michele Iudici, Ulrich A. Walker, Annals of the Rheumatic Diseases	2016	215
Immunochip Analysis Identifies Multiple Susceptibility Loci for Systemic Sclerosis Maureen D. Mayes, Lara Bossini‐Castillo, Olga Y. Gorlova, The American Journal of Human Genetics Autoimmune DiseaseMedicineImmunologySystemic SclerosisAutoimmunity	2014	204

Page 1